Propanc Biopharma PPCB
NASDAQ PPCB
$0.51 -0.02 (-3.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Non-Current Debt (2017 - 2025)

Updated

Propanc Biopharma's Non-Current Debt was $65,280 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 55.0% from $145,091 a year earlier and unchanged from the prior quarter.

Analysis

Propanc Biopharma (PPCB) Non-Current Debt (2017 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Non-Current Debt at Propanc Biopharma came in at $105,627, up 80.1% from FY2024.

  • Non-Current Debt shows a three-year compound annual growth rate of 50.9% (FY2022 to FY2025).
  • In earlier fiscal years, Non-Current Debt was $58,642 in FY2024 (-10.2%), $65,280 in FY2023 (+112.3%) and $30,746 in FY2022.
  • Quarterly Non-Current Debt has moved between $28,581 (fiscal Q1 2024) and $145,091 (fiscal Q2 2025) over five years.
  • Compared with a year earlier, Non-Current Debt was higher in four of the last eight quarters, with growth averaging 96.5%.
  • The best year-over-year quarter for Non-Current Debt over five years was fiscal Q1 2025 (growth of 407.6%); the worst was fiscal Q1 2026 (a decline of 55.0%).
  • Per Business Quant data, PPCB's Non-Current Debt in the three fiscal quarters before Q2 2026 was $65,280 (Q1 2026), $105,627 (Q4 2025) and $93,913 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Propanc Biopharma 595,565.74 595,565.74 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 65,280.00
Sep 30, 2025 65,280.00
Jun 30, 2025 105,627.00
Mar 31, 2025 93,913.00
Dec 31, 2024 145,091.00
Sep 30, 2024 145,091.00
Jun 30, 2024 58,642.00
Mar 31, 2024 48,218.00
Dec 31, 2023 35,214.00
Sep 30, 2023 28,581.00
Jun 30, 2023 65,280.00
Mar 31, 2023 49,558.00
Dec 31, 2022 50,357.00
Jun 30, 2022 30,746.00
Jun 30, 2018 54,753.00
Mar 31, 2018 56,906.00
Jun 30, 2017 56,802.00
API Access

Propanc Biopharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY